After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
GERN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Geron Corp is $942.64M. A total of 8.8 million shares were traded on the day, compared to an average of 13.38M shares.
In the most recent transaction, LAWLIS V BRYAN bought 13,300 shares of GERN for 1.18 per share on May 09 ’25. After the transaction, the Director now owns 13,300 company shares. In a previous transaction on Feb 27 ’25, Samuels Scott Alan bought 15,000 shares at 1.61 per share. GERN shares that EVP, Chief Legal Officer owns now total 26,682.
Among the insiders who bought shares, SCARLETT JOHN A acquired of 12,500 shares on Feb 27 ’25 at a per-share price of $1.76. This resulted in the Chairman, President and CEO holding 12,500 shares of GERN after the transaction. In another insider transaction, Ziegler James bought 100,000 shares at $1.60 per share on Feb 27 ’25. Company shares held by the EVP, Chief Commercial Officer now total 100,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, GERN has a high of $5.34 and a low of $1.17.
As of this writing, GERN has an earnings estimate of -$0.03 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.04.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. GERN’s latest balance sheet shows that the firm has $183.72M in Cash & Short Term Investments as of fiscal 2021. There were $55.00M in debt and $45.52M in liabilities at the time. Its Book Value Per Share was $0.42, while its Total Shareholder’s Equity was $126.42M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GERN is Buy with a score of 4.30.
